Skip to main content

V3651 Pill - white capsule/oblong

Pill with imprint V3651 is White, Capsule/Oblong and has been identified as Fenofibrate 145 mg. It is supplied by AustarPharma, LLC.

Fenofibrate is used in the treatment of Hypertriglyceridemia; High Cholesterol; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for V3651

Fenofibrate

Imprint
V3651
Strength
145 mg
Color
White
Shape
Capsule/Oblong (film coated, modified capsule shape)
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AustarPharma, LLC
National Drug Code (NDC)
35561-0250

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.